CORD-19:775b90287b44353bee979abb0970a4666022f86d / 227340-227488 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Patients were randomized to either continue the same dose of OMA (n=88) or switch to placebo (PLB, n=88) and were followed every 4 weeks for 1 year.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T44693","span":{"begin":0,"end":148},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T44693","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T6","span":{"begin":0,"end":148},"obj":"Sentence"}],"attributes":[{"subj":"T6","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93a9ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#c3ec93"}]}]}}